Clinical Trial Update: Trimetazidine in Pulmonary Artery Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating trimetazidine for pulmonary arterial hypertension; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Trimetazidine (trimetazidine)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Pulmonary Artery Hypertension | Phase 2 | Status: UNKNOWN